Botox injection

ApprovedCompleted
0 views this week 0 watching💤 Quiet
Interest: 33/100
33
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

Cervical Dystonia

Conditions

Cervical Dystonia

Trial Timeline

Dec 1, 2014 → Jan 7, 2017

About Botox injection

Botox injection is a approved stage product being developed by Brain Biotech for Cervical Dystonia. The current trial status is completed. This product is registered under clinical trial identifier NCT02177617. Target conditions include Cervical Dystonia.

What happened to similar drugs?

7 of 20 similar drugs in Cervical Dystonia were approved

Approved (7) Terminated (0) Active (13)

Hype Score Breakdown

Clinical
20
Activity
8
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02177617ApprovedCompleted

Competing Products

20 competing products in Cervical Dystonia

See all competitors
ProductCompanyStageHype Score
PRGN-2009 plus Pembrolizumab + Pembrolizumab alonePrecigenPhase 2
36
ABP-450AEON BiopharmaPhase 2
25
ABP-450 + PlaceboAEON BiopharmaPhase 2
25
Trastuzumab deruxtecanDaiichi SankyoPhase 2
39
exatecan mesylateDaiichi SankyoPhase 2
35
Trastuzumab deruxtecanDaiichi SankyoPhase 2
42
Sacituzumab tirumotecan plus IparomlimabSun PharmaceuticalPhase 2
42
Amolimogene + AmolimogeneEisaiPhase 2/3
38
BOTULINUM TOXIN TYPE BEisaiPhase 2
35
Gemzar (gemcitabine)Eli LillyPhase 3
36
PemetrexedEli LillyPhase 2
35
SHR-A1811 InjectionJiangsu Hengrui MedicinePhase 2
42
camrelizumab; famitinib malate + platinum-based chemotherapyJiangsu Hengrui MedicinePhase 3
44
SHR-1210 + SHR-1020 + Physician's choice chemotherapyJiangsu Hengrui MedicinePhase 2
35
Camrelizumab + Cisplatin or CarboplatinJiangsu Hengrui MedicinePhase 2
31
Camrelizumab + Cisplatin or CarboplatinJiangsu Hengrui MedicinePhase 2
31
Volrustomig + Cisplatin + Carboplatin + PaclitaxelAstraZenecaPhase 2
42
VolrustomigAstraZenecaPhase 3
47
Durvalumab + Cisplatin + CarboplatinAstraZenecaPhase 3
40
VolrustomigAstraZenecaPhase 2
39